Abstract:Influenza virus is a respiratory pathogen that causes a high degree of morbidity and mortality every year in multiple parts of the world. Therefore, precise diagnosis of the infecting strain and rapid high-throughput screening of vast numbers of clinical samples is paramount to control the spread of pandemic infections. Current clinical diagnoses of influenza infections are based on serologic testing, polymerase chain reaction, direct specimen immunofluorescence and cell culture (1,2). Here, we report the development of a novel diagnostic technique used to detect live influenza viruses. We used the mouse-adapted human A/PR/8/34 (PR8, H1N1) virus (3) to test the efficacy of this technique using MDCK cells (4). MDCK cells (10(4) or 5 x 10(3) per well) were cultured in 96- or 384-well plates, infected with PR8 and viral proteins were detected using anti-M2 followed by an IR dye-conjugated secondary antibody. M2 (5) and hemagglutinin (1) are two major marker proteins used in many different diagnostic assays. Employing IR-dye-conjugated secondary antibodies minimized the autofluorescence associated with other fluorescent dyes. The use of anti-M2 antibody allowed us to use the antigen-specific fluorescence intensity as a direct metric of viral quantity. To enumerate the fluorescence intensity, we used the LI-COR Odyssey-based IR scanner. This system uses two channel laser-based IR detections to identify fluorophores and differentiate them from background noise. The first channel excites at 680 nm and emits at 700 nm to help quantify the background. The second channel detects fluorophores that excite at 780 nm and emit at 800 nm. Scanning of PR8-infected MDCK cells in the IR scanner indicated a viral titer-dependent bright fluorescence. A positive correlation of fluorescence intensity to virus titer starting from 10(2)-10(5) PFU could be consistently observed. Minimal but detectable positivity consistently seen with 10(2)-10(3) PFU PR8 viral titers demonstrated the high sensitivity of the near-IR dyes. The signal-to-noise ratio was determined by comparing the mock-infected or isotype antibody-treated MDCK cells. Using the fluorescence intensities from 96- or 384-well plate formats, we constructed standard titration curves. In these calculations, the first variable is the viral titer while the second variable is the fluorescence intensity. Therefore, we used the exponential distribution to generate a curve-fit to determine the polynomial relationship between the viral titers and fluorescence intensities. Collectively, we conclude that IR dye-based protein detection system can help diagnose infecting viral strains and precisely enumerate the titer of the infecting pathogens.

[The rapid detection kit based on neuraminidase activity of influenza virus].

A rapid influenza diagnostic test based on detection of viral neuraminidase activity

Rapid Detection of Influenza A Viruses Using a Real-Time Reverse Transcription Recombinase-Aided Amplification Assay.

Development of a Rapid Test Kit for Detection of Influenza A Virus Specific Nucleoproteins

A rapid test for the detection of influenza A virus including pandemic influenza A/H1N1 2009.

Rapid Subtyping of H9N2 Influenza Virus by a Triple Reverse Transcription Polymerase Chain Reaction.

One Method of Fast Detection for Influenza A Virus

A Simple and Rapid Immunochromatographic Strip Test for Detection of Influenza B Viruses

A practical and rapid screening method for influenza virus neuraminidase inhibitors based on fluorescence detection

A HRP-labeled lateral flow immunoassay for rapid simultaneous detection and differentiation of influenza A and B viruses.

A Rapid On-Site Assay for the Detection of Influenza A by Capillary Convective PCR

An HRP‐labeled lateral flow immunoassay for rapid simultaneous detection and differentiation of influenza A and B viruses

Comparison of a New Gold Immunochromatographic Assay for the Rapid Diagnosis of the Novel Influenza A (H7N9) Virus with Cell Culture and a Real-Time Reverse-Transcription PCR Assay.

High-throughput Detection Method for Influenza Virus.

Development and evaluation of a TaqMan MGB RT-PCR assay for detection of H5 and N8 subtype influenza virus

Development of a multi-recombinase polymerase amplification assay for rapid identification of COVID-19, influenza A and B

Rapid detection of influenza virus A by fluorescence quantitative RT-PCR]

Quick Test for the Early Diagnosis of Influenza

Rapid Assessment of Neutralizing Antibodies Using Influenza Viruses with a Luciferase Reporter

A Rapid Method for Detecting Flu A+B Antigens and Its Application

Evaluation of a Novel Micro/nanofluidic Chip Platform for the Detection of Influenza A and B Virus in Patients with Influenza-Like Illness